Urogen Pharma Ltd (URGN)

SBC to Revenue

7.36%

Quarterly · Period ending:

URGN logo

URGN SBC to Revenue

Latest reported7.36%
URGN Quarterly SBC/Revenue (0.00% → 7.36%)
High-resolution chart · PNG

URGN sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd SBC to Revenue — Quarterly
Period endingSBC to Revenue
7.3576%
9.0798%
8.2723%
11.0145%
11.2864%
15.1526%
13.446%
13.843%
16.2944%
14.6744%
11.0965%
10.6656%
10.5114%
13.2969%
13.0887%
0%
17.0019%
21.7414%
33.1211%
48.586%
46.3935%
82.7655%
81.9232%
195.406%
1,913.7097%
0%
0%
0%
40,066.6667%
0%
0%
3,362.1908%
2,117.8571%
944.0748%
693.8838%
27.6242%
0%
1,563.1579%
3.3143%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.